Amy Welsh
Corporate Officer/Principal presso AGILE THERAPEUTICS, INC.
Patrimonio netto: 19 089 $ in data 30/06/2024
Posizioni attive di Amy Welsh
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AGILE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2022 | - |
| Vendite & Marketing | 01/05/2020 | 01/11/2022 |
Storia della carriera di Amy Welsh
Precedenti posizioni note di Amy Welsh
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ANTARES PHARMA, INC. | Vendite & Marketing | 01/06/2017 | 01/05/2020 |
Formazione di Amy Welsh
| LaSalle University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Sales & Marketing | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AGILE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
- Borsa valori
- Insiders
- Amy Welsh
- Esperienza
